Nuzenio

First Patient To

First Patient To news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Akeso Doses First Patient in Phase 2 Trial of Bispecific ADC AK146D1 Plus Ivonescimab in Breast Cancer - BioPharm InternationalBioPharm International · Mon, 10 Aug 2026 16:47:15 GMTFirst patient dosed with AK146D1 in Akeso’s Phase II study - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 13:34:39 GMTArtelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 13:03:06 GMTArtelo Tests an Oral Cannabinoid for Glaucoma Eye Pressure - Stock TitanStock Titan · Mon, 10 Aug 2026 12:47:00 GMTAkeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 04:31:46 GMTInnovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - BioPharma APACBioPharma APAC · Sat, 08 Aug 2026 16:11:09 GMTFirst Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 13:04:40 GMTFirst patient dosed with DISP-10 in Dispatch Bio’s cancer trial - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:11:48 GMT

Timeline

Mon, 10 Aug 2026 16:47:15 GMTAkeso Doses First Patient in Phase 2 Trial of Bispecific ADC AK146D1 Plus Ivonescimab in Breast Cancer - BioPharm International
Mon, 10 Aug 2026 13:34:39 GMTFirst patient dosed with AK146D1 in Akeso’s Phase II study - Clinical Trials Arena
Mon, 10 Aug 2026 13:03:06 GMTArtelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma - The Manila Times
Mon, 10 Aug 2026 12:47:00 GMTArtelo Tests an Oral Cannabinoid for Glaucoma Eye Pressure - Stock Titan
Mon, 10 Aug 2026 04:31:46 GMTAkeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila Times
Sat, 08 Aug 2026 16:11:09 GMTInnovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - BioPharma APAC

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for First Patient To.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.